Status:
COMPLETED
Early Community Client-LED ART Delivery in Nakivale Refugee Settlement
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
HIV Seropositivity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To pilot early community client-led ART (anti-retroviral therapy) delivery (CCLAD) in Nakivale Refugee Settlement in Uganda and assess the feasibility and acceptability of this intervention in this se...
Detailed Description
Adults accessing routine HIV testing in Nakivale Refugee Settlement will be invited to participate. The study population will include adult refugees and Ugandan nationals of all genders older than 18 ...
Eligibility Criteria
Inclusion
- • Adults ≥ 18 years of age who present to the Nakivale Health Center and agree/consent to test for HIV.
Exclusion
- Unable to understand one of the study languages (English, Kinyarwanda, Kiswahili, Runyankore).
- Subjects who do not test positive for HIV at health center will not be eligible to participate in the early community-based client-led antiretroviral therapy delivery intervention
Key Trial Info
Start Date :
June 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT04736316
Start Date
June 29 2020
End Date
March 31 2022
Last Update
July 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nakivale Refugee Settlement
Isingiro, Uganda